Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners
Launched by EMORY UNIVERSITY · Feb 1, 2024
Trial Information
Current as of October 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a 6-week online program designed to help older adults with memory issues, like dementia, and their caregivers improve their sleep. The goal is to see if this program is easy to use, acceptable, and truly helps both the individuals with memory loss and their caregivers, whether they participate together or separately.
To be eligible for this study, participants must be aged 65 or older and have a diagnosis of Alzheimer's disease or related memory issues. They should also experience sleep problems at least three times a week. Caregivers must be at least 18 years old and live with someone experiencing cognitive impairment, regularly helping them with daily activities. Participants can expect to join online sessions where they will learn skills to enhance their sleep quality. This study is currently recruiting participants, so if you or someone you know fits the criteria, it could be a great opportunity to find support and improve sleep.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for the PLwCI:
- • Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), or caregiver-reported probable or possible cognitive impairment based on electronic medical records or prescribed medications or
- • Montreal Cognitive Assessment (MOCA) score between 12 and 24;
- • Had ≥1 sleep problem ≥3x/week on the Neuropsychiatric Inventory (NPI)-Nighttime Behavior Subscale;
- • Have an eligible caregiver;
- • Be able to participate meaningfully in an interview
- Inclusion Criteria for Caregivers:
- • ≥18 years old, co-residing with persons living with cognitive impairment (PLwCI);
- • Regularly assist the care recipient with ≥1 of 7 basic activities of daily living or
- • ≥1 of 7 Instrumental Activities of Daily Living for the past 6 months;
- • Have a Pittsburgh Sleep Quality Index (PSQI) of 5 or greater
- Exclusion Criteria:
- • PLwCI: Moderate to severe cognitive impairment
- • Individuals who are not yet adults
- • Pregnant women
- • Prisoners
- • Individuals who are not able to clearly understand English.
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Glenna Brewster, PhD, RN, FNP
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported